Stock Earnings in Review: ImmunoGen, Inc.

Stock Earnings in Review: ImmunoGen, Inc.

ImmunoGen, Inc. (NASDAQ:IMGN) is expected to report two quarter earnings before the open on Friday, January 29, with a conference call scheduled for 8:00 pm EST. ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics.

(Visited 1 times, 1 visits today)
12
Like
Save

Comments

Comments are disabled for this post.